Hematology/Oncology

Top Story

Radiofrequency ablation reduces neoplastic progression in Barrett's esophagus

September 2, 2015

Patients with Barrett’s esophagus and confirmed low-grade dysplasia who underwent radiofrequency ablation had lower rates of neoplastic progression, according to new research data.

To determine the rate of progression of low-grade dysplasia to high-grade dysplasia or esophageal adenocarcinoma (EAC) in patients with BE who underwent radiofrequency ablation compared with endoscopic surveillance alone, Meenakshi Bewtra, MD, PhD, MPH, from the Perelman School of Medicine, University of Pennsylvania, and colleagues performed a retrospective study of patients from three U.S. referral centers within the Barrett’s Esophagus Translational Research Network (BETRNet).

Hayden McRobbie In the Journals

Carbon monoxide, acrolein decrease in smokers who switch to e-cigarettes

September 2, 2015
E-cigarette use in smokers who quit and in dual users demonstrated a significant decrease in tobacco smoke toxicant exposure, according to study results.“We found…
In the Journals

Survival favorable among younger patients with rectal cancer despite unfavorable tumor morphology

September 2, 2015
Younger patients with rectal cancer have comparable survival outcomes as middle-aged patients despite more frequently presenting with advanced disease and unfavorable…
In the Journals

Erivedge shows promise as treatment for radiation-induced multiple BCCs

September 2, 2015
Erivedge provided a significant clinical response and was a relatively safe alternative therapy for patients with radiation-induced multiple basal cell carcinomas…
Susan M. O’Brien, MD In the Journals

Intensification of rituximab fails to benefit untreated patients with CLL

September 1, 2015
Additional doses of rituximab did not improve responses rates among patients with chronic lymphocytic leukemia treated with the chemotherapy combination of fludarabine…
More News Headlines »
CME
Hematology Oncology Case Consults

The Patient with Invasive Breast Cancer

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with invasive breast cancer.
More »
Meeting News Coverage Video
VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

VIDEO: PALOMA-3 trial represents 'enormous gain' for patients with hormone-positive breast cancer

August 20, 2015
CHICAGO — The PALOMA-3 trial, which evaluated the addition of palbociclib to fulvestrant, demonstrated…
More »
CME
Hematology Oncology Case Consults

The Patient with Multiple Myeloma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with multiple myeloma.
More »
morganatic-roan